Report Description

United States bioinformatics market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing biotechnological procedures and techniques. Also, rising technical advancements like nucleic acid and protein sequencing, genetic engineering, and storage of the then found data and its analysis further drives the growth of the United States bioinformatics market in the upcoming five years. Rising demands for the biotechnological procedures for advancing medicine, finding the cure for diseases etc. also supports the growth of the United States bioinformatics market in the next five years.

Application of the tools of computation and analysis to collection and interpretation of the biological data is termed as bioinformatics. A conjugation of multiple fields like medicine, computer science, mathematics, physics, forms bioinformatics. Moreover, the storage of the human genome project data and other similar genomic projects aids to the growing requirements of bioinformatics. The storage of the genome mapping data helps in analyzing underlying genomes and thus translated protein information of any new species. Microorganisms like bacteria, virus, fungi have tendency to mutate rapidly. The infectious diseases thus caused often leads to the urgency for devising treatments and vaccines against the microbes. The recent pandemic is one such example that actively utilized functions of bioinformatics in formulating the genome mapping of the coronavirus and its strain along with the vaccine and the pharmaceuticals.

Prevalence of Rare Diseases Promises Market Growth

Rapid outbreaks of new diseases and growing prevalence of infectious diseases with unidentified strains of microorganisms, and their adversities drive the growth of the United States bioinformatics market in the upcoming five years. The definition of rare diseases in the country depends on the population it affects in a country or a region for a prolonged period of time. In the United States, if a disease affects less than 200,000 people it is categorized as a rare disease. In the recent times, the rare diseases along with the infections have grown rapidly and affected large population in the country.

Recent pandemic affected the worldwide population. In United States, over 81 million cases have been recorded in the country by March 2022 where 997,933 people died due to COVID-19. The United States was one of the few countries that came up with the vaccination and pharmaceuticals for the viral infection, and the use of bioinformatics for the purpose was a boon. Therefore, the prevalent nature of such infectious diseases would support the growth of the United States bioinformatics market in the next five years.

Technological Advancement Guides Market Growth

Growing advancement in the biotechnological procedures and processes drives the market growth. Moreover, the evolution of big data technology is also fueling the technical advancement in the bioinformatics field. Using the technology for the analysis of the protein structure, functions, and further predictive analysis is substantiating the growth of the United States bioinformatics market in the future five years. Moreover, developments in systems biology and genomic analysis of pharmaceuticals have helped personalized medicine to transit from disease-centered and reductionism-based medical practice to system-based, integrative, and human-centered care.

Furthermore, increasing investment for the research and advancement in the bioinformatic systems & services is another major factor aiding the growth of the United States bioinformatics market. In the year 2021, USD597.26 billion was spent over research and development in the healthcare sector. A large section was involved in pharmaceutical advancement and data storage regarding new protein translations, thus substantiating market growth in the country.

Click here to download the sample

Market Segmentation

The United States bioinformatics market is segmented by product & services, type, application, end user, competitional landscape, and regional distribution. Based on product & services, the market is further segmented into bioinformatics tools, bioinformatics platforms, and bioinformatics services. By type, the market is fragmented into genomics & proteomics, simulation studies & molecular modelling, genetic engineering, and others. Based on application, the market is bifurcated into metagenomics, drug discovery, precision medicine, and others. By end user, the market is differentiated between institutional research and industrial research. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among South region, Mid-West region, North-East region, and West region.

Company Profile

Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe, DataTrack International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA GENETICS, among others is a partial list of major market players of the companies responsible for the growth of United States bioinformatics market.



Base Year


Historical Data

2017 – 2020

Estimated Year


Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Product & Services
  • Type
  • Application
  • End User

Regional scope

South region, Mid-West region, North-East region, and West region.

Key companies profiled

Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe, DataTrack International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA GENETICS

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, United States bioinformatics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Bioinformatics Market, By Product & Services:
    • Bioinformatics Tools
    • Bioinformatics Platforms
    • Bioinformatics Services
  • United States Bioinformatics Market, By Type:
    • Genomics & Proteomics
    • Simulation Studies & Molecular Modelling
    • Genetic Engineering
    • Others
  • United States Bioinformatics Market, By Application:
    • Metagenomics
    • Drug Discovery
    • Precision Medicine
    • Others
  • United States Bioinformatics Market, By End User:
    • Institutional Research
    • Industrial Research
  • United States Bioinformatics Market, By Region:

o   South Region

o   Mid-West Region

o   North-East Region

o   West Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States bioinformatics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States Bioinformatics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Bioinformatics Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Bioinformatics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product & Services (Bioinformatics Tools, Bioinformatics Platforms, Bioinformatics Services)

6.2.2.     By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others)

6.2.3.     By Application (Metagenomics, Drug Discovery, Precision Medicine, Others)

6.2.4.     By End User (Institutional Research v/s Industrial Research)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    United States Bioinformatics Tools Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Application

7.2.3.     By End User

8.    United States Bioinformatics Platforms Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Application

8.2.3.     By End User

9.    United States Bioinformatics Services Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Application

9.2.3.     By End User

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Developments

12.  Policy & Regulatory Landscape

13.  United States Economic Profile

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.2.1.  Illumina, Inc.

14.2.2.  Thermo Fischer Scientific, Inc.

14.2.3.  Agilent Technologies, Inc.

14.2.4.  PerkinElmer Inc.

14.2.5.  QIAGEN Inc.

14.2.6.  23AndMe

14.2.7.  DataTrack International, Inc.

14.2.8.  Biovia-Dassault Systemes

14.2.9.  Waters Corporation

14.2.10.                SOPHiA GENETICS

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions


The United States bioinformatics market is expected to register growth with anticipated CAGR on account of growing demands for biological data storage with techniques for information storage, distribution, and analysis.


New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.


Being responsible for the due growth of the market, some of the leading players of the United States bioinformatics market were Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., among others.


United States bioinformatics market was analyzed for the historical period of 2017 to 2020. While the base year was 2021, estimation for the year 2022 was calculated and the market growth was further forecast for 2023 to 2027.


Sakshi Bajaal

Business Consultant
Press Release

United States Bioinformatics Market to Grow with Impressive CAGR until 2027

May, 2022

United States Bioinformatics Market is anticipated to grow with growing investments in the healthcare industry, in the forecast period, 2023-2027F.